Installer Kaleta App
Accès rapide & mode hors-ligne
Accelerating the development of vaccines to prevent HIV and other infectious diseases.
The International AIDS Vaccine Initiative (IAVI) was founded in 1996 with the mission to accelerate the development of vaccines to prevent HIV and other infectious diseases. Headquartered in New York, USA, IAVI operates globally with a significant presence in Africa, where the burden of HIV/AIDS is most acute. The organization collaborates with governments, academia, and industry partners to advance scientific research and innovation in vaccine development, aiming to address urgent global health challenges.
IAVI’s operations are extensive, with research and development programs spanning multiple continents. The organization has established partnerships with African research institutions to conduct clinical trials and build local scientific capacity. IAVI’s efforts have led to significant advancements in HIV vaccine research and have expanded to include other infectious diseases such as tuberculosis and emerging pathogens. The initiative’s work has contributed to the socio-economic development of communities by improving health outcomes and fostering scientific expertise in the regions it serves.
IAVI has a strategic focus on regions heavily affected by HIV/AIDS, particularly in sub-Saharan Africa. Key countries of intervention include Kenya, Uganda, Rwanda, and South Africa, where IAVI collaborates with local research institutions to conduct clinical trials and enhance scientific infrastructure.
IAVI’s flagship initiatives include the development of innovative vaccine candidates and the establishment of regional laboratories and research centers in Africa. The organization also provides funding opportunities for collaborative research projects and capacity-building programs aimed at strengthening local health systems.
IAVI has achieved significant milestones in advancing HIV vaccine candidates through various stages of clinical trials. The organization has been instrumental in fostering international collaborations and has contributed to the training of hundreds of scientists and healthcare professionals in Africa, enhancing the region’s research capabilities and public health responses.
